Galmed Pharmaceuticals Ownership | Who Owns Galmed Pharmaceuticals?

Galmed Pharmaceuticals Ownership Summary

Galmed Pharmaceuticals is owned by 122.72% institutional investors. Delaware Healthcare I is the top mutual fund, with 0.11% of its assets in Galmed Pharmaceuticals shares.

GLMD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Galmed Pharmaceuticals	122.72%	-	-22.72%
Sector	Healthcare Stocks	47.25%	8.01%	44.75%
Industry	Biotech Stocks	45.35%	7.81%	46.83%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Delaware Healthcare I	1.70K	0.11%	-
Fidelity Nasdaq Composite Index	152.00	0.01%	1.00
Blackstone Alternative Multi-Strategy I	407.00	0.00%	-93.00

GLMD Ownership FAQ

Who Owns Galmed Pharmaceuticals?

Galmed Pharmaceuticals shareholders are primarily institutional investors at 122.72%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Galmed Pharmaceuticals's industry, Biotech Stocks , is 45.35%, which Galmed Pharmaceuticals exceeds.

Does Blackrock own Galmed Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Galmed Pharmaceuticals.

Who is the top mutual fund holder of Galmed Pharmaceuticals shares?

Delaware Healthcare I is the top mutual fund holder of Galmed Pharmaceuticals shares, with 0.11% of its total shares outstanding invested in 1.7K Galmed Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools